Cite
HARVARD Citation
Du, C. et al. (2020). 1q21 gain but not t(4;14) indicates inferior outcomes in multiple myeloma treated with bortezomib. Leukemia & lymphoma. 61 (5), pp. 1201-1210. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Du, C. et al. (2020). 1q21 gain but not t(4;14) indicates inferior outcomes in multiple myeloma treated with bortezomib. Leukemia & lymphoma. 61 (5), pp. 1201-1210. [Online].